Upstream Bio (UPB) Non Operating Income (2023 - 2026)

Upstream Bio's Non Operating Income history runs 4 years deep, the most recent figure standing at -$30000.0 for Q1 2026.

• In Q1 2026, Non Operating Income changed N/A year-over-year to -$30000.0; the TTM figure through Mar 2026 stood at -$4.8 million (down 183.08% YoY), while the FY2025 annual figure was -$15000.0, up 37.5% from the prior year.
• Non Operating Income was -$30000.0 for Q1 2026 at Upstream Bio, up from -$13.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $19.7 million in Q4 2023 to a low of -$13.2 million in Q4 2025.
• Historically, Non Operating Income has averaged $3.0 million across 4 years, with a median of $2.9 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Non Operating Income plunged 53.84% in 2024, then jumped 53.07% in 2025.
• A 4-year view of Non Operating Income shows it stood at $19.7 million in 2023, then slumped by 85.26% to $2.9 million in 2024, then plunged by 555.88% to -$13.2 million in 2025, then soared by 99.77% to -$30000.0 in 2026.
• The last three Non Operating Income figures came in at -$30000.0 (Q1 2026), -$13.2 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.